Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
Saved in:
| Title: | Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial. |
|---|---|
| Authors: | Kankasa C; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Mennecier A; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Sakana BLD; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Molès JP; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Mwiya M; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Chunda-Liyoka C; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., D'Ottavi M; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Tassembedo S; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Wilfred-Tonga MM; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Fao P; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Rutagwera D; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Matoka B; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Kania D; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Taofiki OA; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Tylleskär T; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Van de Perre P; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France. Electronic address: n-nagot@chu-montpellier.fr. |
| Corporate Authors: | PROMISE-EPI Trial Group |
| Source: | Lancet (London, England) [Lancet] 2024 Apr 06; Vol. 403 (10434), pp. 1362-1371. Date of Electronic Publication: 2024 Mar 11. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
